ES2494617B1 - Uso de la Garvicina A como producto antimicrobiano - Google Patents

Uso de la Garvicina A como producto antimicrobiano Download PDF

Info

Publication number
ES2494617B1
ES2494617B1 ES201300260A ES201300260A ES2494617B1 ES 2494617 B1 ES2494617 B1 ES 2494617B1 ES 201300260 A ES201300260 A ES 201300260A ES 201300260 A ES201300260 A ES 201300260A ES 2494617 B1 ES2494617 B1 ES 2494617B1
Authority
ES
Spain
Prior art keywords
garvicin
antimicrobial product
antimicrobial
product
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201300260A
Other languages
English (en)
Other versions
ES2494617A1 (es
Inventor
Alicia Gibello Prieto
Mª Del Mar BLANCO GUTIÉRREZ
Juan Miguel Rodríguez Gómez
Nivia CARDENAS CARDENAS
José Francisco FERNÁNDEZ-GARAYZABAL FERNÁNDEZ
Lucas José DOMÍNGUEZ RODRÍGUEZ
Antonio Maldonado Barragán
Mª Carmen ASPIROZ SANCHO
Ana Isabel DE LAS HERAS SÁNCHEZ
Juan José INFANTE VIÑOLO
Víctor Manuel INFANTE VIÑOLO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIONATURIS
Universidad Complutense de Madrid
Original Assignee
BIONATURIS
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIONATURIS, Universidad Complutense de Madrid filed Critical BIONATURIS
Priority to ES201300260A priority Critical patent/ES2494617B1/es
Priority to CN201480024715.9A priority patent/CN105188730A/zh
Priority to PCT/ES2014/000027 priority patent/WO2014140391A1/es
Publication of ES2494617A1 publication Critical patent/ES2494617A1/es
Application granted granted Critical
Publication of ES2494617B1 publication Critical patent/ES2494617B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/70Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729Organic compounds; Microorganisms; Enzymes
    • A23B2/7295Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Uso de la Garvicina A como producto antimicrobiano.#La invención consiste en el uso de la Garvicina A como producto antimicrobiano la forma de obtención de la Garvicina A mediante aislamiento natural o de manera recombinante, así como la aplicación de formulaciones que comprenden Garvicina A como compuesto antimicrobiano de uso en salud animal, salud humana e industria alimentaria.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32
imagen33
imagen34
imagen35
imagen36
imagen37
imagen38
imagen39
imagen40
imagen41
imagen42
imagen43
imagen44

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
ES201300260A 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano Expired - Fee Related ES2494617B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES201300260A ES2494617B1 (es) 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano
CN201480024715.9A CN105188730A (zh) 2013-03-15 2014-03-03 用作抗菌产品的Garvicin A
PCT/ES2014/000027 WO2014140391A1 (es) 2013-03-15 2014-03-03 Uso de la garvicina a como producto antimicrobiano

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201300260A ES2494617B1 (es) 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano

Publications (2)

Publication Number Publication Date
ES2494617A1 ES2494617A1 (es) 2014-09-15
ES2494617B1 true ES2494617B1 (es) 2015-06-11

Family

ID=51493128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201300260A Expired - Fee Related ES2494617B1 (es) 2013-03-15 2013-03-15 Uso de la Garvicina A como producto antimicrobiano

Country Status (3)

Country Link
CN (1) CN105188730A (es)
ES (1) ES2494617B1 (es)
WO (1) WO2014140391A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229939B (zh) * 2011-05-25 2013-01-23 青岛根源生物技术集团有限公司 一种优化的高活性人溶菌酶基因及其表达载体和应用

Also Published As

Publication number Publication date
CN105188730A (zh) 2015-12-23
ES2494617A1 (es) 2014-09-15
WO2014140391A1 (es) 2014-09-18

Similar Documents

Publication Publication Date Title
IL273182A (en) Rearing insect larvae
IL310614A (en) Nutritional formula
CL2015002494S1 (es) Producto alimenticio para mascotas. (divisional solicitud 457-2014)
JP2014026276A5 (es)
JP2014026274A5 (es)
JP2015509368A5 (es)
JP2014189812A5 (es)
MX2017010293A (es) 2-tioimidazolilcarboxamidas sustituidas como pesticidas.
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
JP2015107586A5 (es)
MX2017005756A (es) Producto alimenticio para mascotas extruido.
JP2015518513A5 (es)
CL2013000654A1 (es) Procedimiento de tratamiento fungicida, bactericida y/o antioxidante de articulos alimentarios que comprende la aplicación de formulación de aceite esencial y/o sus constituyentes o sus mezclas en un dialquilenglicol.
GB2566689B (en) Insect larvae rearing
PL2991642T3 (pl) Kompozycje przeciwdrobnoustrojowe do zastosowania w leczeniu zapalenia sutka u przeżuwaczy
JP2015514031A5 (es)
EP2987417A4 (en) MUSHROOM EXTRACT AND FLAVORING AGENT
JP2015127764A5 (es)
JP2014193955A5 (es)
CL2016001584A1 (es) Composiciones y métodos para aumentar la palatabilidad de alimentos secos para mascotas
ES2494617B1 (es) Uso de la Garvicina A como producto antimicrobiano
CL2013003808A1 (es) Formulacion veterinaria que comprende un extracto etanolico de s. adenotrichius dc donde el extracto etanolico comprende un compuesto sesquiterpeno eremofilano de formula i; uso para prevenir, controlar o eliminar garrapatas o sus larvas en un animal o humano, y en el entorno de los mismos.
IL268952B (en) Formulation of stearyl alcohol
LT2942050T (lt) Purškiama aliejinga kompozicija riebaluose tirpių d grupės vitaminų pagrindu, ir jos panaudojimas
GB201404459D0 (en) Animal hydrating composition with luring effect

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2494617

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150611

FD2A Announcement of lapse in spain

Effective date: 20210928